SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-23-025605
Filing Date
2023-02-27
Accepted
2023-02-27 06:50:06
Documents
1
Effectiveness Date
2023-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 POS tm237887d4_s8pos.htm S-8 POS 27794
  Complete submission text file 0001104659-23-025605.txt   28893
Mailing Address C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035
Business Address C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-237103 | Film No.: 23669993
SIC: 2836 Biological Products, (No Diagnostic Substances)